Assessment of Gold Nanoparticles-Inhibited Cytochrome P450 3A4 Activity and Molecular Mechanisms Underlying Its Cellular Toxicity in Human Hepatocellular Carcinoma Cell Line C3A

about

Assessment of Gold Nanoparticles-Inhibited Cytochrome P450 3A4 Activity and Molecular Mechanisms Underlying Its Cellular Toxicity in Human Hepatocellular Carcinoma Cell Line C3A

Item

http://www.wikidata.org/entity/Q58754807

description

article

@en

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Assessment of Gold Nanoparticl ...... llular Carcinoma Cell Line C3A

@en

Assessment of Gold Nanoparticl ...... llular Carcinoma Cell Line C3A

@nl

type

Item

label

Assessment of Gold Nanoparticl ...... llular Carcinoma Cell Line C3A

@en

Assessment of Gold Nanoparticl ...... llular Carcinoma Cell Line C3A

@nl

prefLabel

Assessment of Gold Nanoparticl ...... llular Carcinoma Cell Line C3A

@en

Assessment of Gold Nanoparticl ...... llular Carcinoma Cell Line C3A

@nl

P1476

Assessment of Gold Nanoparticl ...... llular Carcinoma Cell Line C3A

@en

P2093

Hyun Joo

http://www.w3.org/2001/XMLSchema#string

Kyoungju Choi

http://www.w3.org/2001/XMLSchema#string

P2860

A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation

Toxic potential of materials at the nanolevel

Experimental considerations on the cytotoxicity of nanoparticles

The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective.

Size- and time-dependent alteration in metabolic activities of human hepatic cytochrome P450 isozymes by gold nanoparticles via microsomal coincubations

Recent advances in nonviral vectors for gene delivery.

Severely Impaired and Dysregulated Cytochrome P450 Expression and Activities in Hepatocellular Carcinoma: Implications for Personalized Treatment in Patients.

New therapies for hepatocellular carcinoma.

Epidemiology of hepatocellular carcinoma: consider the population.

Application of doxorubicin-induced rAAV2-p53 gene delivery in combined chemotherapy and gene therapy for hepatocellular carcinoma

P2888

s11671-018-2684-1

P304

279

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S11671-018-2684-1

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106911767

http://www.w3.org/2001/XMLSchema#string

P698

30203228

http://www.w3.org/2001/XMLSchema#string

P921

condensed matter physics

P932

6134879

http://www.w3.org/2001/XMLSchema#string